5-Benzyloxynicotinic acid methyl ester, 98%, 500mg

2,3,4,6-Tetra-O-acetyl-D-glucopyranose, 97%, 5g

2-diazenyl-2-hydroxy-N-(pentan-3-yl)acetamide, 95%, 500mg

1-Pyridin-4-yl-[1,4]diazepane, 95.0%, 5g

N-benzyl-6-chloropyridazin-3-amine, 95.0%, 250mg

N-[(1R*,4R*)-4-Aminocyclohexyl]-4-chlorobenzamide hydrochloride, 1g

Analytical and precision scale Entris® II series Models with external adjustment, not certified, 0.001 g, 320 g, BCE323-1S (W)

Methyl 5-(2-bromophenyl)isoxazole-3-carboxylate, 95.0%, 5g

2-Methylthiazole-4-carboxylic Acid>98.0%(GC)(T)5g

2-(4-Bromophenyl)-2-oxoethyl trifluoromethanesulfonate, 95.0%, 250mg

2-[3-(trifluoromethyl)phenyl]piperidine hydrochloride, 95%, 1g

Efaproxiral Sodium>98.0%(HPLC)(T)250mg

tert-Butyl 3-(2-aminoethyl)azetidine-1-carboxylate, 95.0%, 5g